Pharmacological properties of angiotensin II antagonists: Examining all the therapeutic implications

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 2, Issue SUPPL. 2, 2001, Pages

  Unger, Thomas ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Angiotensin II AT1 receptors; Angiotensin II AT2 receptors; Coronary artery ligation; Spontaneously hypertensive rats

Indexed keywords

ANGIOTENSIN II;

ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; HYPERTENSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ANGIOTENSIN II; ANIMALS; HUMANS; HYPERTENSION; RENIN-ANGIOTENSIN SYSTEM;

EID: 0035633439     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2001.030     Document Type: Article

References (5)

1. Zhu YZ, Zhu YC, Li J et al. Effects of losartan on haemodynamic parameters and angiotensin receptor mRNA levels in rat heart after myocardial infarction. JRAAS 2000;1:257-62.
2. Inada Y, Wada T, Ojima M et al. Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens 1997;19:1079-99.
3. Rajagopalan S, Kurz S, Munzel T et al. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996;97:1916-23.
4. 2-receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension 1998;31:349-55.
5. Yusuf S, Sleight P, Pogue J et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-53.